Whole Exome Sequencing Market -Global Trends and Forecasts(2025 to 2034)
Description
Whole Exome Sequencing Market Size And Forecast
Whole Exome Sequencing Market was valued at USD 1.22 Billion in 2025 and is projected to reach USD 7.54illion by 2027, growing at a CAGR of 22.3% from 2020 to 2027.
Global Whole Exome Sequencing Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Factview Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The Global Whole Exome Sequencing Market is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market.
Global Whole Exome Sequencing Market Competitive Landscape
The Global Whole Exome Sequencing Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Roche NimbleGen, Inc., Illumina, Inc., Agilent Technologies, Life Technologies (acquired by Thermo Fisher Scientific, Inc.), BGI, Knome, Inc., Eurofins Genomics, Inc., Macrogen, Inc., Sengenics, and GENEWIZ, Inc.
Whole Exome Sequencing Market was valued at USD 1.22 Billion in 2025 and is projected to reach USD 7.54illion by 2027, growing at a CAGR of 22.3% from 2020 to 2027.
Global Whole Exome Sequencing Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Factview Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The Global Whole Exome Sequencing Market is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market.
Global Whole Exome Sequencing Market Competitive Landscape
The Global Whole Exome Sequencing Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Roche NimbleGen, Inc., Illumina, Inc., Agilent Technologies, Life Technologies (acquired by Thermo Fisher Scientific, Inc.), BGI, Knome, Inc., Eurofins Genomics, Inc., Macrogen, Inc., Sengenics, and GENEWIZ, Inc.
Table of Contents
202 Pages
- 1 Introduction Of Global Whole Exome Sequencing Market
- 1.1 Overview Of The Market
- 1.2 Scope Of Report
- 1.3 Assumptions
- 2 Executive Summary
- 3 Research Methodology Of Factview Research
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List Of Data Sources
- 4 Global Whole Exome Sequencing Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Whole Exome Sequencing Market, By Product
- 5.1 Overview
- 5.2 Systems
- 5.3 Kits
- 5.4 Services
- 6 Global Whole Exome Sequencing Market, By Technology
- 6.1 Overview
- 6.2 Sequencing By Synthesis
- 6.3 Ion Semiconductor Sequencing
- 6.4 Others
- 7 Global Whole Exome Sequencing Market, By Application
- 7.1 Overview
- 7.2 Diagnostics
- 7.3 Drug Discovery And Development
- 7.4 Personalized Medicine
- 7.5 Others
- 8 Global Whole Exome Sequencing Market, By Geography
- 8.1 Overview
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest Of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest Of Asia Pacific
- 8.5 Rest Of The World
- 8.5.1 Latin America
- 8.5.2 Middle East
- 9 Global Whole Exome Sequencing Market Competitive Landscape
- 9.1 Overview
- 9.2 Company Market Ranking
- 9.3 Key Development Strategies
- 10 Company Profiles
- 10.1 Roche Nimblegen, Inc.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
- 10.2 Illumina, Inc.
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
- 10.3 Agilent Technologies
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
- 10.4 Life Technologies (Acquired By Thermo Fisher Scientific, Inc.)
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
- 10.5 Bgi
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
- 10.6 Knome, Inc.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
- 10.7 Eurofins Genomics, Inc.
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
- 10.8 Macrogen, Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
- 10.9 Sengenics
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
- 10.10 Genewiz, Inc.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
- 11 Appendix
- 11.1 Related Research
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

